AI Article Synopsis
- Octreotide is essential for managing neuroendocrine tumors around the time of surgery.
- There is no single best treatment plan for using octreotide in these cases.
- The article reviews the research supporting its use at various stages of the surgical process.
Article Abstract
Octreotide is the cornerstone of perioperative management of neuroendocrine tumours, but there is no universal agreement on the optimal regimen. This article discusses the evidence for its use during different parts of the perioperative pathway.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12968/hmed.2023.0193 | DOI Listing |
Publication Analysis
Top Keywords
perioperative management
8
neuroendocrine tumours
8
management patients
4
patients neuroendocrine
4
tumours octreotide
4
octreotide cornerstone
4
cornerstone perioperative
4
management neuroendocrine
4
tumours universal
4
universal agreement
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!